Romosozumab versus alendronate and fracture risk in women with osteoporosis

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Number of pages1
JournalNew England Journal of Medicine
Volume378
Issue number2
DOIs
Publication statusPublished - 2018 Jan 11

Fingerprint

Alendronate
Osteoporosis
AMG 785

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{3f5a248a9bf84791bed686917ae47335,
title = "Romosozumab versus alendronate and fracture risk in women with osteoporosis",
author = "Song, {Gwan Gyu} and Lee, {Young Ho}",
year = "2018",
month = "1",
day = "11",
doi = "10.1056/NEJMc1714810",
language = "English",
volume = "378",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "2",

}

TY - JOUR

T1 - Romosozumab versus alendronate and fracture risk in women with osteoporosis

AU - Song, Gwan Gyu

AU - Lee, Young Ho

PY - 2018/1/11

Y1 - 2018/1/11

UR - http://www.scopus.com/inward/record.url?scp=85041106809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041106809&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1714810

DO - 10.1056/NEJMc1714810

M3 - Letter

C2 - 29322751

AN - SCOPUS:85041106809

VL - 378

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 2

ER -